ASAP.ST

Asarina Pharma AB (publ) [ASAP.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

ASAP.ST Stock Summary

In the News

ASAP.ST Financial details

Company Rating
-
Market Cap
20.56M
Income
-12.03K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1
Optionable
No
Shortable
Yes
Earnings
23 Feb 2024
P/E
-1.85
Forward P/E
-
PEG
0.28
P/S
-
P/B
1.68
P/C
-
P/FCF
-1.94
Quick Ratio
6.02
Current Ratio
6.95
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.56
EPS next Y
-
EPS next Q
-
EPS this Y
-57.99%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-79%
ROE
-74%
ROC
-1.01%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.596-1.645
52W High
-
52W Low
-
RSI
-
Rel Volume
51.67
Avg Volume
25.24K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.412
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
MSFT
AAPL
MIX.JO
AMZN
TSLA
Same Sector
RWLK
ENZY.ST
ABMC
SIEN
MGTX
Check Those
MXDU
603185.SS
ESEA.DE
009275.KS
GBSP.L
Similar Market Cap
TTO.DE
PAIC
8507.HK
HGTXU
SYBX

Company Profile

Healthcare Biotechnology
  • Volume Average 25.24K
  • Market Capitalization 20.56M
  • Employee 1
  • CEO Mr. Peter Nordkild M.D.
  • Headquarters Solna,SE
  • IPO Date 2018-09-24
  • Website https://www.asarinapharma.com

Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.